{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:20:52Z","timestamp":1785853252007,"version":"3.56.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR AR050236 R01"],"award-info":[{"award-number":["AR AR050236 R01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR AR050236 R56"],"award-info":[{"award-number":["AR AR050236 R56"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Knock-in homozygote VCPR155H\/R155H mutant mice are a lethal model of valosin-containing protein (VCP)-associated inclusion body myopathy associated with Paget disease of bone, frontotemporal dementia and amyotrophic lateral sclerosis. Ceramide (d18:1\/16:0) levels are elevated in skeletal muscle of the mutant mice, compared to wild-type controls. Moreover, exposure to a lipid-enriched diet reverses lethality, improves myopathy and normalizes ceramide levels in these mutant mice, suggesting that dysfunctions in lipid-derived signaling are critical to disease pathogenesis. Here, we investigated the potential role of ceramide in VCP disease using pharmacological agents that manipulate the ceramide levels in myoblast cultures from VCP mutant mice and VCP patients. Myoblasts from wild-type, VCPR155H\/+ and VCPR155H\/R155H mice, as well as patient-induced pluripotent stem cells (iPSCs), were treated with an inhibitor of ceramide degradation to increase ceramide via acid ceramidase (ARN082) for proof of principle. Three chemically distinct inhibitors of ceramide biosynthesis via serine palmitoyl-CoA transferase (L-cycloserine, myriocin or ARN14494) were used as a therapeutic strategy to reduce ceramide in myoblasts. Acid ceramidase inhibitor, ARN082, elevated cellular ceramide levels and concomitantly enhanced pathology. Conversely, inhibitors of ceramide biosynthesis L-cycloserine, myriocin and ARN14494 reduced ceramide production. The results point to ceramide-mediated signaling as a key contributor to pathogenesis in VCP disease and suggest that manipulating this pathway by blocking ceramide biosynthesis might exert beneficial effects in patients with this condition. The ceramide pathway appears to be critical in VCP pathogenesis, and small-molecule inhibitors of ceramide biosynthesis might provide therapeutic benefits in VCP and related neurodegenerative diseases.<\/jats:p>","DOI":"10.1093\/hmg\/ddaa248","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T12:19:21Z","timestamp":1609935561000},"page":"3945-3953","source":"Crossref","is-referenced-by-count":14,"title":["Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-8725","authenticated-orcid":false,"given":"Lan","family":"Weiss","sequence":"first","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6953","authenticated-orcid":false,"given":"Kwang-Mook","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Anatomy & Neurobiology, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angele","family":"Nalbandian","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"},{"name":"Department of Ophthalmology, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Llewellyn","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-8609","authenticated-orcid":false,"given":"Lac","family":"Ta","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Migliore","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, 16162, Italy"},{"name":"Aptuit (Verona) Srl, Verona, 37135 Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Squire","sequence":"additional","affiliation":[{"name":"Department of Anatomy & Neurobiology, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizy","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Anatomy & Neurobiology, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[{"name":"Department of Anatomy & Neurobiology, University of California-Irvine, Irvine, CA, USA"},{"name":"Pharmaceutical Sciences, University of California-Irvine, Irvine, CA, USA"},{"name":"Biological Chemistry, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-4449","authenticated-orcid":false,"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[{"name":"Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, CA, USA"},{"name":"Department of Neurology, University of California-Irvine, Irvine, CA, USA"},{"name":"Department of Pathology, University of California-Irvine, Irvine, CA, USA"},{"name":"Division of Occupational and Environmental Medicine, Department of Medicine, University of California-Irvine, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"2021100109324600100_ref1","article-title":"Inclusion Body Myopathy with Paget Disease of Bone and\/or Frontotemporal Dementia. 2007 May 25 [Updated 2019 Sep 12].","author":"Kimonis","year":"1993"},{"key":"2021100109324600100_ref2","first-page":"1993","volume-title":"Gene Reviews\u00ae","author":"Kimonis","year":"1993"},{"key":"2021100109324600100_ref3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng1332","article-title":"Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein","volume":"36","author":"Watts","year":"2004","journal-title":"Nat. Genet."},{"key":"2021100109324600100_ref4","first-page":"3877","article-title":"The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis","volume":"127","author":"Meyer","year":"2014","journal-title":"J. Cell Sci."},{"key":"2021100109324600100_ref5","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1038\/s41388-018-0651-z","article-title":"The coordinated action of VCP\/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation","volume":"38","author":"Parzych","year":"2019","journal-title":"Oncogene"},{"key":"2021100109324600100_ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 Misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"2021100109324600100_ref7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/hmg\/ddt523","article-title":"Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease","volume":"23","author":"Llewellyn","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"2021100109324600100_ref8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4161\/auto.22739","article-title":"Ceramide stress in survival versus lethal autophagy paradox: ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"9","author":"Jiang","year":"2013","journal-title":"Autophagy"},{"key":"2021100109324600100_ref9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nchembio.1059","article-title":"Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"8","author":"Sentelle","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"2021100109324600100_ref10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbalip.2013.09.005","article-title":"Autophagy paradox and ceramide","volume":"1841","author":"Jiang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2021100109324600100_ref11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"2021100109324600100_ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.numecd.2013.05.004","article-title":"Ceramides are associated with inflammatory processes in human mediastinal adipose tissue","volume":"24","author":"Gertow","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"2021100109324600100_ref13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"2021100109324600100_ref14","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/cmdc.201300327","article-title":"Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease","volume":"8","author":"Schonemann","year":"2013","journal-title":"Chem Med Chem"},{"key":"2021100109324600100_ref15","first-page":"1","volume-title":"Emery and Rimoin's Principles and Practice of Medical Genetics (Sixth Edition)","author":"Desnick","year":"2013"},{"key":"2021100109324600100_ref16","first-page":"113","article-title":"Fabry disease: molecular genetics of the inherited nephropathy","volume":"18","author":"Desnick","year":"1989","journal-title":"Adv. Nephrol. Necker Hosp."},{"key":"2021100109324600100_ref17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jeu.12043","article-title":"Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes","volume":"60","author":"Castro","year":"2013","journal-title":"J. Eukaryot. Microbiol."},{"key":"2021100109324600100_ref18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/jgh.12291","article-title":"Ceramide inhibitor myriocin restores insulin\/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis","volume":"28","author":"Lizarazo","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2021100109324600100_ref19","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/ja4059876","article-title":"The chemical basis of serine palmitoyltransferase inhibition by myriocin","volume":"135","author":"Wadsworth","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"2021100109324600100_ref20","volume-title":"International Patent Classification: C07D 401\/04 (2006.01); C07D 401\/14 (2006.01); A61K 31\/454 (2006.01)","author":"Bolton","year":"2006"},{"key":"2021100109324600100_ref21","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","author":"Kurek","year":"2013","journal-title":"Liver Int."},{"key":"2021100109324600100_ref22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/srep01035","article-title":"Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity","volume":"3","author":"Realini","year":"2013","journal-title":"Sci. Rep."},{"key":"2021100109324600100_ref23","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/jm301879g","article-title":"Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR)","volume":"56","author":"Pizzirani","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021100109324600100_ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-59745-157-4_11","article-title":"Sphingolipids in macroautophagy","volume":"445","author":"Lavieu","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"2021100109324600100_ref25","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","article-title":"Ketogenic diet slows down mitochondrial myopathy progression in mice","volume":"19","author":"Ahola-Erkkila","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021100109324600100_ref26","doi-asserted-by":"crossref","DOI":"10.1096\/fj.12-205807","article-title":"High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism","author":"Camargo","year":"2012","journal-title":"FASEB J."},{"key":"2021100109324600100_ref27","doi-asserted-by":"crossref","first-page":"113031","DOI":"10.1016\/j.expneurol.2019.113031","article-title":"A neutral lipid-enriched diet improves myelination and alleviates peripheral nerve pathology in neuropathic mice","volume":"321","author":"Zhou","year":"2019","journal-title":"Exp. Neurol."},{"key":"2021100109324600100_ref28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021100109324600100_ref29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10495-011-0589-x","article-title":"Conversation between apoptosis and autophagy: \"is it your turn or mine?\"","volume":"16","author":"Giansanti","year":"2011","journal-title":"Apoptosis"},{"key":"2021100109324600100_ref30","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J. Lipid Res."},{"key":"2021100109324600100_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021100109324600100_ref32","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/cr2002917","article-title":"Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics","volume":"111","author":"Merrill","year":"2011","journal-title":"Chem. Rev."},{"key":"2021100109324600100_ref33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1080\/15548627.2018.1511218","article-title":"Why do we need to regulate autophagy (and how can we do it)? A cartoon depiction","volume":"14","author":"Klionsky","year":"2018","journal-title":"Autophagy"},{"key":"2021100109324600100_ref34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/15548627.2018.1446628","article-title":"Why do we need autophagy? A cartoon depiction","volume":"14","author":"Klionsky","year":"2018","journal-title":"Autophagy"},{"key":"2021100109324600100_ref35","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-020-0511-6","article-title":"Autophagy participates in, well, just about everything","author":"Klionsky","year":"2020","journal-title":"Cell Death Differ."},{"key":"2021100109324600100_ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"2021100109324600100_ref37","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1074\/jbc.M313561200","article-title":"Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1","volume":"279","author":"Scarlatti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021100109324600100_ref38","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/brain\/aww237","article-title":"Exosome secretion is a key pathway for clearance of pathological TDP-43","volume":"139","author":"Iguchi","year":"2016","journal-title":"Brain"},{"key":"2021100109324600100_ref39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1194\/jlr.S092874","article-title":"Advances in determining signaling mechanisms of ceramide and role in disease","volume":"60","author":"Stith","year":"2019","journal-title":"J. Lipid Res."},{"key":"2021100109324600100_ref40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12944-019-1118-0","article-title":"Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis","volume":"18","author":"Yang","year":"2019","journal-title":"Lipids Health Dis."},{"key":"2021100109324600100_ref41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.scr.2018.05.017","article-title":"Efficient and high yield isolation of myoblasts from skeletal muscle","volume":"30","author":"Shahini","year":"2018","journal-title":"Stem Cell Res."},{"key":"2021100109324600100_ref42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/acschemneuro.8b00556","article-title":"Inhibition of serine Palmitoyltransferase by a small organic molecule promotes neuronal survival after astrocyte amyloid Beta 1-42 injury","volume":"10","author":"De Vita","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2021100109324600100_ref43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-60761-322-0_10","article-title":"Lipidomic analysis of biological samples by liquid chromatography coupled to mass spectrometry","volume":"579","author":"Astarita","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"2021100109324600100_ref44","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.21769\/BioProtoc.2248","article-title":"Isolation, culturing, and differentiation of primary myoblasts from skeletal muscle of adult mice","volume":"7","author":"Hindi","year":"2017","journal-title":"Bio-protocol"},{"key":"2021100109324600100_ref45","doi-asserted-by":"crossref","first-page":"e0116961","DOI":"10.1371\/journal.pone.0116961","article-title":"Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis","volume":"10","author":"Astarita","year":"2015","journal-title":"PLoS One"},{"key":"2021100109324600100_ref46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/mus.23522","article-title":"A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H\/+) mouse","volume":"47","author":"Nalbandian","year":"2013","journal-title":"Muscle Nerve"},{"key":"2021100109324600100_ref47","doi-asserted-by":"crossref","first-page":"e0176919","DOI":"10.1371\/journal.pone.0176919","article-title":"Myogenic differentiation of VCP disease-induced pluripotent stem cells: a novel platform for drug discovery","volume":"12","author":"Llewellyn","year":"2017","journal-title":"PLoS One"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddaa248\/36288367\/ddaa248.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/29\/24\/3945\/40492646\/ddaa248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/29\/24\/3945\/40492646\/ddaa248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T16:51:52Z","timestamp":1633107112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/29\/24\/3945\/6056025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":47,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,1,7]]},"published-print":{"date-parts":[[2021,2,25]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaa248","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,15]]},"published":{"date-parts":[[2020,12,15]]}}}